Cargando…
Efficacy of rituximab and plasmapharesis in an adult patient with antifactor H autoantibody-associated hemolytic uremic syndrome: A case report and literature review
Antifactor H antibody (anti-CFHAb) is found in 6% to 25% cases of atypical hemolytic uremic syndrome (aHUS) in children, but has been only exceptionally reported in adults. There is no consensus about the best treatment for this type of aHUS. We report the case of an adult patient treated successful...
Autores principales: | Deville, Clemence, Garrouste, Cyril, Coppo, Paul, Evrard, Bertrand, Lautrette, Alexandre, Heng, Anne Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265956/ https://www.ncbi.nlm.nih.gov/pubmed/27684863 http://dx.doi.org/10.1097/MD.0000000000005007 |
Ejemplares similares
-
Efficacy of eculizumab in an adult patient with HIV-associated hemolytic uremic syndrome: A case report
por: Freist, Marine, et al.
Publicado: (2017) -
Cobalamin c deficiency associated with antifactor h antibody-associated hemolytic uremic syndrome in a young adult
por: Philipponnet, C., et al.
Publicado: (2020) -
Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia: A case report and literature review
por: Chen, Minguang, et al.
Publicado: (2017) -
Atypical hemolytic uremic syndrome and acute tubular necrosis induced by complement factor B gene (CFB) mutation: A case report
por: Wu, Hao, et al.
Publicado: (2021) -
A Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and Hemodialysis
por: Wu, Hon-Yen, et al.
Publicado: (2016)